Professor David Owens
Swansea University Medical School
Telephone: (01792) 513400
Email: JavaScript is required to view this email address.


  1. Comment on the FLAT-SUGAR Trial Investigators. Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk. Diabetes Care 2016;39:973–981. Diabetes Care 39(10), e186-e187.
  2. & Differential effects of glucagon-like peptide-1 receptor agonists on heart rate. Cardiovascular Diabetology 16(1)
  3. & Recombinant Human Insulin in Global Diabetes Management – Focus on Clinical Efficacy. European Endocrinology 13(01), 21
  4. & Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/ml added to oral antidiabetes agents in type 2 diabetes. Diabetes, Obesity and Metabolism
  5. & Future challenges and therapeutic opportunities in type 2 diabetes: changing the paradigm of current therapy. Diabetes, Obesity and Metabolism

See more...


  • Self Monitoring of Blood Glucose (SMBG) in non insulin treated type 2 diabetes (current)

    Student name:
    Other supervisor: Prof Stephen Luzio
    Other supervisor: Prof David Owens
  • Untitled (current)

    Student name:
    Other supervisor: Dr Chenfeng Li
    Other supervisor: Prof David Owens